AC Immune Ltd (NASDAQ:ACIU)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Leerink Swann in a research note issued to investors on Saturday.
Several other equities analysts have also recently issued reports on the company. Credit Suisse Group AG began coverage on AC Immune in a report on Tuesday, October 18th. They set an “outperform” rating and a $18.00 price objective for the company. Jefferies Group began coverage on AC Immune in a report on Tuesday, October 18th. They set a “buy” rating and a $25.00 price objective for the company.
AC Immune (NASDAQ:ACIU) traded up 9.37% on Friday, reaching $12.61. The company had a trading volume of 269,075 shares. AC Immune has a 52-week low of $10.36 and a 52-week high of $19.97. The company’s market capitalization is $624.74 million. The company’s 50-day moving average is $14.16 and its 200-day moving average is $14.83.